Search research articles
Contact Us
Filters
Showing results (101-110 of 109) with videos related to
Page
of 11
Sort By:
You have reached the last page of results.
This site can display upto 109 results.
Leukemia
|
October 12, 2007
Prognostic significance of molecular-cytogenetic abnormalities in pediatric T-ALL is not explained by immunophenotypic differences
M van Grotel, J P P Meijerink, E R van Wering, et al.
Leukemia
|
June 1, 2002
BFM-oriented treatment for children with acute lymphoblastic leukemia without cranial irradiation and treatment reduction for standard risk patients: results of DCLSG protocol ALL-8 (1991-1996)
W A Kamps, J P M Bökkerink, F G A J Hakvoort-Cammel, et al.
Blood
|
August 10, 1999
Intensive treatment of children with acute lymphoblastic leukemia according to ALL-BFM-86 without cranial radiotherapy: results of Dutch Childhood Leukemia Study Group Protocol ALL-7 (1988-1991)
W A Kamps, J P Bökkerink, K Hählen, et al.
Leukemia
|
July 30, 2010
Clinical significance of flowcytometric minimal residual disease detection in pediatric acute myeloid leukemia patients treated according to the DCOG ANLL97/MRC AML12 protocol
V H J van der Velden, A van der Sluijs-Geling, B E S Gibson, et al.
Leukemia
|
March 23, 1999
Myelodysplastic syndrome, juvenile myelomonocytic leukemia, and acute myeloid leukemia associated with complete or partial monosomy 7. European Working Group on MDS in Childhood (EWOG-MDS)
H Hasle, M Aricò, G Basso, et al.
Leukemia
|
June 11, 2010
Preemptive alloimmune intervention in high-risk pediatric acute lymphoblastic leukemia patients guided by minimal residual disease level before stem cell transplantation
A C Lankester, M B Bierings, E R van Wering, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 30, 2003
Patient stratification based on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemia
M L Den Boer, D O Harms, R Pieters, et al.
Lancet (London, England)
|
December 16, 1998
Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood
J J van Dongen, T Seriu, E R Panzer-Grümayer, et al.
Leukemia
|
April 2, 2010
EVI1 overexpression in distinct subtypes of pediatric acute myeloid leukemia
B V Balgobind, S Lugthart, I H Hollink, et al.
Page
of 11
Search research articles
Search
Showing results (101-110 of 109) with videos related to
Sort By:
Page
of 11
You have reached the last page of results.
This site can display upto 109 results.
Leukemia
|
October 12, 2007
Prognostic significance of molecular-cytogenetic abnormalities in pediatric T-ALL is not explained by immunophenotypic differences
M van Grotel, J P P Meijerink, E R van Wering, et al.
Leukemia
|
June 1, 2002
BFM-oriented treatment for children with acute lymphoblastic leukemia without cranial irradiation and treatment reduction for standard risk patients: results of DCLSG protocol ALL-8 (1991-1996)
W A Kamps, J P M Bökkerink, F G A J Hakvoort-Cammel, et al.
Blood
|
August 10, 1999
Intensive treatment of children with acute lymphoblastic leukemia according to ALL-BFM-86 without cranial radiotherapy: results of Dutch Childhood Leukemia Study Group Protocol ALL-7 (1988-1991)
W A Kamps, J P Bökkerink, K Hählen, et al.
Leukemia
|
July 30, 2010
Clinical significance of flowcytometric minimal residual disease detection in pediatric acute myeloid leukemia patients treated according to the DCOG ANLL97/MRC AML12 protocol
V H J van der Velden, A van der Sluijs-Geling, B E S Gibson, et al.
Leukemia
|
March 23, 1999
Myelodysplastic syndrome, juvenile myelomonocytic leukemia, and acute myeloid leukemia associated with complete or partial monosomy 7. European Working Group on MDS in Childhood (EWOG-MDS)
H Hasle, M Aricò, G Basso, et al.
Leukemia
|
June 11, 2010
Preemptive alloimmune intervention in high-risk pediatric acute lymphoblastic leukemia patients guided by minimal residual disease level before stem cell transplantation
A C Lankester, M B Bierings, E R van Wering, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 30, 2003
Patient stratification based on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemia
M L Den Boer, D O Harms, R Pieters, et al.
Lancet (London, England)
|
December 16, 1998
Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood
J J van Dongen, T Seriu, E R Panzer-Grümayer, et al.
Leukemia
|
April 2, 2010
EVI1 overexpression in distinct subtypes of pediatric acute myeloid leukemia
B V Balgobind, S Lugthart, I H Hollink, et al.
Page
of 11